Dalena Tran

Array ( [id] => 4099650 [patent_doc_number] => 06048888 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Method and pharmaceutical formulation for treating benign prostatic hyperplasia' [patent_app_type] => 1 [patent_app_number] => 8/976508 [patent_app_country] => US [patent_app_date] => 1997-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6000 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048888.pdf [firstpage_image] =>[orig_patent_app_number] => 976508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4052812 [patent_doc_number] => 05932611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Angiogenesis inhibitor for the treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 8/975813 [patent_app_country] => US [patent_app_date] => 1997-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 4980 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932611.pdf [firstpage_image] =>[orig_patent_app_number] => 975813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045777 [patent_doc_number] => 05912265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Pharmaceutical compositions containing flavanolignanes and methods for using same as an antiproliferative' [patent_app_type] => 1 [patent_app_number] => 8/952415 [patent_app_country] => US [patent_app_date] => 1997-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2277 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912265.pdf [firstpage_image] =>[orig_patent_app_number] => 952415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3976178 [patent_doc_number] => 05916924 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Remedies for liver diseases' [patent_app_type] => 1 [patent_app_number] => 8/971267 [patent_app_country] => US [patent_app_date] => 1997-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 6155 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916924.pdf [firstpage_image] =>[orig_patent_app_number] => 971267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3912957 [patent_doc_number] => 06001828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Use of tumor factor inhibitors together with antiviral agents and therapeutic compositions thereof against HIV infection' [patent_app_type] => 1 [patent_app_number] => 8/956277 [patent_app_country] => US [patent_app_date] => 1997-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2853 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001828.pdf [firstpage_image] =>[orig_patent_app_number] => 956277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998414 [patent_doc_number] => 05922775 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Method of treating malignant tumors with ketone thyroxine analogues having no significant hormonal activity' [patent_app_type] => 1 [patent_app_number] => 8/956711 [patent_app_country] => US [patent_app_date] => 1997-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10174 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922775.pdf [firstpage_image] =>[orig_patent_app_number] => 956711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158089 [patent_doc_number] => 06114395 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Method of treating atherosclerosis' [patent_app_type] => 1 [patent_app_number] => 8/955313 [patent_app_country] => US [patent_app_date] => 1997-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4834 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114395.pdf [firstpage_image] =>[orig_patent_app_number] => 955313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1561644 [patent_doc_number] => 06362184 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => '1, 2, 4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents' [patent_app_type] => B1 [patent_app_number] => 08/951873 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 13610 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/362/06362184.pdf [firstpage_image] =>[orig_patent_app_number] => 08951873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3923895 [patent_doc_number] => 05914321 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Antitumoral method by administration of partricin derivatives' [patent_app_type] => 1 [patent_app_number] => 8/953751 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3187 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914321.pdf [firstpage_image] =>[orig_patent_app_number] => 953751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4119278 [patent_doc_number] => 06071948 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Methods and compositions for inhibition of angiogenesis' [patent_app_type] => 1 [patent_app_number] => 8/950673 [patent_app_country] => US [patent_app_date] => 1997-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6374 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071948.pdf [firstpage_image] =>[orig_patent_app_number] => 950673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305268 [patent_doc_number] => 06187817 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds' [patent_app_type] => 1 [patent_app_number] => 8/942845 [patent_app_country] => US [patent_app_date] => 1997-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 12003 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187817.pdf [firstpage_image] =>[orig_patent_app_number] => 942845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171795 [patent_doc_number] => 06140362 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Method for inhibiting the growth of mammalian cells' [patent_app_type] => 1 [patent_app_number] => 8/939516 [patent_app_country] => US [patent_app_date] => 1997-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11982 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 290 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140362.pdf [firstpage_image] =>[orig_patent_app_number] => 939516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992662 [patent_doc_number] => 05891884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Use of an imidazole derivative for preventing and/or treating rhinitis' [patent_app_type] => 1 [patent_app_number] => 8/937358 [patent_app_country] => US [patent_app_date] => 1997-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2688 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891884.pdf [firstpage_image] =>[orig_patent_app_number] => 937358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4019404 [patent_doc_number] => 05906993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-25 [patent_title] => 'Treating disorders characterized by excessive cell proliferation with sclareolide' [patent_app_type] => 1 [patent_app_number] => 8/875476 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1954 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/906/05906993.pdf [firstpage_image] =>[orig_patent_app_number] => 875476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3987353 [patent_doc_number] => 05910485 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-08 [patent_title] => 'Antitumor agents comprising as the principal compounds containing silicon and nitrogen' [patent_app_type] => 1 [patent_app_number] => 8/913219 [patent_app_country] => US [patent_app_date] => 1997-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2675 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/910/05910485.pdf [firstpage_image] =>[orig_patent_app_number] => 913219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3983853 [patent_doc_number] => 05958941 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs' [patent_app_type] => 1 [patent_app_number] => 8/925485 [patent_app_country] => US [patent_app_date] => 1997-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2787 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958941.pdf [firstpage_image] =>[orig_patent_app_number] => 925485 [rel_patent_id] =>[rel_patent_doc_number] =>)